Schering-Plough awarded media duties in the US to MediaVest, a subsidiary of Publicis Groupe.

Seidler Bernstein won a branding and marketing assignment from venture-backed medical device company OmniSonics Medical Technologies to develop and implement a full branding initiative, behind the devicemaker's OmniWave product.

Sudler & Hennessey (S&H) has been selected by AstraZeneca as the global agency partner of record for the developmental arthritis treatment PN400.

MedThink Communications has been retained by Salix Pharmaceuticals to launch and promote its newest product under development, an orally disintegrating form of metoclopramide.

OrthoNeutrogena, a division of Ortho-McNeil Pharmaceuticals, has selected Stratagem Healthcare Communications to handle the company's marketing and branding initiatives for Renova (tretinoin cream 0.02%) indicated to reduce fine facial lines associated with chronic sun exposure when used as part of a comprehensive skin care program.

Allergan awarded Pacific Communications the DTC assignment for its severe axillary hyperhidrosis (severe underarm sweating) indication on Botox following a competitive pitch.

Shire Pharmaceuticals tapped InVentiv's Palio to handle professional advertising and promotion for Fosrenol, which is indicated for hyperphosphatemia in patients with end stage renal disease.

GlaxoSmithKline should be finished transitioning the media planning and buying for its North American OTC business by the end of February, a spokesperson for the drugmaker said.

Griff/SMC, has been chosen as agency of record by Med-Aesthetic Solutions, a Cardiff, CA,-based provider of practice building services and technologies used in aesthetic medicine.

Lazur Hoyvald Goldstein Partners has been chosen agency of record by Medical Resources, Inc. to provide branding and marketing services for the corporation's network of fixed-site outpatient medical diagnostic imaging centers.